201 related articles for article (PubMed ID: 4164172)
21. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
[No Abstract] [Full Text] [Related]
22. [Results of the inoculation test of measles vaccine. 2. The results of the use of inactivated measles vaccine alone and combined inactivated and attenuated live virus vaccine].
Santo K
Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):344-55. PubMed ID: 6070597
[No Abstract] [Full Text] [Related]
23. Live measles vaccine from a further attenuated strain SEVAC.
Mares I; Drevo M; Adam E; Kubátová M; Casny J
Prog Immunobiol Stand; 1967; 3():188-91. PubMed ID: 5379938
[No Abstract] [Full Text] [Related]
24. [Postvaccinal measles immunity characteristics of Leningrad children].
Smorodinova IP; Zubov AK; Sobolevskaia AA; Kaplan AS; Smordintsev AA
Tr Inst Im Pastera; 1979; 53():66-70. PubMed ID: 162464
[No Abstract] [Full Text] [Related]
25. [Vaccination against measles].
Cocchi P; Corti R
Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
[TBL] [Abstract][Full Text] [Related]
26. [Study of clinical reactions and the fluctuation of antibody levels after measles vaccination. (1) Clinical reactions and serum antibody values after vaccination with raw vaccine only].
Kubota K
Nihon Shonika Gakkai Zasshi; 1967 Dec; 71(12):1478-83. PubMed ID: 4175590
[No Abstract] [Full Text] [Related]
27. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination.
Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K
Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008
[No Abstract] [Full Text] [Related]
28. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
[No Abstract] [Full Text] [Related]
29. [Serum titration of children vaccinated against measles].
Morzycka M; Barteczkoi
Pediatr Pol; 1968 Jul; 43(7):813-6. PubMed ID: 4174897
[No Abstract] [Full Text] [Related]
30. Studies with live attenuated measles-virus vaccine. Comparative clinical, antigenic, and prophylactic effects after inoculation with and without gamma-globulin.
KRUGMAN S; GILES JP; JACOBS AM; FRIEDMAN H
Am J Dis Child; 1962 Mar; 103():353-63. PubMed ID: 14459920
[No Abstract] [Full Text] [Related]
31. Population immunity to measles in the United States, 1999.
Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
[TBL] [Abstract][Full Text] [Related]
32. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
33. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
Revenok ND
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
[No Abstract] [Full Text] [Related]
34. Evaluation of the live AIK measles virus vaccine.
Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
Kitasato Arch Exp Med; 1973 Dec; 46(3-4):83-92. PubMed ID: 4805362
[No Abstract] [Full Text] [Related]
35. [Study on the long-term observation of measles vaccine immunity. 2. 2-Mercaptoethanol-sensitive antibody].
Tsukada Y
Nihon Shonika Gakkai Zasshi; 1968 Apr; 72(4):488-93. PubMed ID: 5692410
[No Abstract] [Full Text] [Related]
36. Development of extremely attenuated live measles virus vaccine (CAM-EX).
Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
[No Abstract] [Full Text] [Related]
37. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
[No Abstract] [Full Text] [Related]
38. [Development of measles vaccination in Austria].
Huber EG; Rannon L
Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
[No Abstract] [Full Text] [Related]
39. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
[No Abstract] [Full Text] [Related]
40. Measles immunity and immunization in developing countries of Africa: a review.
Abdurrahman MB; Taqi AM
Afr J Med Med Sci; 1981; 10(1-2):57-62. PubMed ID: 6287828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
